Time trends in 20 years of medication use in older adults: Findings from three elderly cohorts in Stockholm, Sweden

Archives of Gerontology and Geriatrics

Volumn 63, Issue , 2016, Pages 28-35

  Craftman, Åsa Gransjön ^a   Johnell, Kristina ^b   Fastbom, Johan ^b   Westerbotn, Margareta ^c   von Strauss, Eva ^d  

^a SOPHIAHEMMET UNIVERSITY COLLEGE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Department of Research   (Germany)

^d Red Cross University College   (Sweden)

Author keywords

Medication use; Older adults; Polypharmacy; Population based; Time trends

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; HYPNOTIC AGENT; OPIATE; PSYCHOTROPIC AGENT; SEDATIVE AGENT; NEUROLEPTIC AGENT;

AGED; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; DRUG UTILIZATION; EDUCATIONAL STATUS; ELDERLY CARE; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; SWEDEN; TREND STUDY; VERY ELDERLY; ADULT; HEALTH SURVEY; MIDDLE AGED; ODDS RATIO; PRESCRIPTION; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRENDS;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYPHARMACY; POPULATION SURVEILLANCE; PREVALENCE; PSYCHOTROPIC DRUGS; SWEDEN;

EID: 84958206309     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2015.11.010     Document Type: Article

References (49)

1. Armitage P., Berry G. Statistical methods in medical research 1987, Blackwell Scientific, Oxford.
2. Barnett K., Mercer S.W., Norbury M., Watt G., Wyke S., Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012, 380(9836):37-43.
3. Chapman D.P., Perry G.S. Depression as a major component of public health for older adults. Preventing Chronic Disease 2008, 5(1):A22.
4. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and treatment of high blood pressure. Hypertension 2003, 42(6):1206-1252.
5. Christensen K., Doblhammer G., Rau R., Vaupel J.W. Ageing populations: the challenges ahead. Lancet 2009, 374(9696):1196-1208.
6. Cumming R.G., Le Couteur D.G. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003, 17(11):825-837.
7. Egger S.S., Ratz Bravo A.E., Hess L., Schlienger R.G., Krahenbuhl S. Age-related differences in the prevalence of potential interactions in ambulatory dyslipidaemic patients treated with statins. Drugs & Aging 2007, 24(5):429-440.
8. Fick D.M., Cooper J.W., Wade W.E., Waller J.L., Maclean J.R., Beers M.H. Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Archives of Internal Medicine 2003, 163(22):2716-2724.
9. Folstein M., Folstein S., McHugh P. Mini-mental state': a practical method for grading cognitive state of patients for the clinicians. Journal of Psychiatric Research 1975, 12:189-198.
10. Fors S., Lennartsson C., Agahi N., Parker M.G., Thorslund M. Interview study on the living conditions of the very old. Elderly acquire more health problems, but they manage everyday life better. Lakartidningen 2013, 110(32-33):1403-1405.
11. Franchi C., Tettamanti M., Pasina L., Djignefa C.D., Fortino I., Bortolotti A., et al. Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000-2010. European Journal of Clinical Pharmacology 2014, 70(4):437-443.
12. Fratiglioni L., Grut M., Forsell Y., et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991, 41(12):1886.
13. Fratiglioni L., Viitanen M., Backman L., Sandman P.O., Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992, 11(Suppl. 1):29-36.
14. Friberg J., Buch P., Scharling H., Gadsbphioll N., Jensen G.B. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003, 14(6):666-672.
15. Fux R., Greiner D., Geldmacher M., Morike K., Gleiter C.H. Multiple drug prescribing by general practitioners in a German region: implications for drug interactions and patient safety. International Journal of Clinical Pharmacology and Therapeutics 2006, 44(11):539-547.
16. Gibson S.J. IASP global year against pain in older persons: highlighting the current status and future perspectives in geriatric pain. Expert Review of Neurotherapeutics 2007, 7(6):627-635.
17. Gnjidic D., Hilmer S.N., Blyth F.M., et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Journal of Clinical Epidemiology 2012, 65(9):989-995.
18. Grace A.R., Briggs R., Kieran R.E., et al. A comparison of beers and STOPP criteria in assessing potentially inappropriate medications in nursing home residents attending the emergency department. Journal of the American Medical Directors Association 2014, 15(11):830-834.
19. Guthrie B., McCowan C., Davey P., Simpson C.R., Dreischulte T., Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011, 342:d3514.
20. Haasum Y., Fastbom J., Fratiglioni L., Kareholt I., Johnell K. Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly. Drugs & Aging 2011, 28(4):283-293.
21. Haasum Y., Fastbom J., Johnell K. Institutionalization as a risk factor for inappropriate drug use in the elderly: a Swedish nationwide register-based study. The Annals of Pharmacotherapy 2012, 46(3):339-346.
22. Haider S.I., Johnell K., Thorslund M., Fastbom J. Trends in polypharmacy and potential interactions across educational groups in elderly patients in Sweden for the period 1992-2002. International Journal of Clinical Pharmacology and Therapeutics 2007, 45(12):643-653.
23. Haider S.I., Johnell K., Ringback Weitoft G., Thorslund M., Fastbom J. Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people. European Journal of Clinical Pharmacology 2008, 64(12):1215-1222.
24. Haider S.I., Johnell K., Thorslund M., Fastbom J. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden. Clinical Therapeutics 2008, 30(2):419-427.
25. Haider S.I., Johnell K., Weitoft G.R., Thorslund M., Fastbom J. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. Journal of the American Geriatrics Society 2009, 57(1):62-69.
26. Hartikainen S., Mantyselka P., Louhivuori-Laako K., Enlund H., Sulkava R. Concomitant use of analgesics and psychotropics in home-dwelling elderly people-Kuopio 75+ study. British Journal of Clinical Pharmacology 2005, 60(3):306-310.
27. Hegeman J.M., de Waal M.W., Comijs H.C., Kok R.M., van der Mast R.C. Depression in later life: a more somatic presentation?. Journal of Affective Disorders 2014, 170C:196-202.
28. Helme R.D., Gibson S.J. The epidemiology of pain in elderly people. Clinics in Geriatric Medicine 2001, 17(3):417-431.
29. Johnell K., Fastbom J. Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. Drugs & Aging 2012, 29(9):751-758.
30. Johnell K., Weitoft G.R., Fastbom J. Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. The Annals of Pharmacotherapy 2009, 43(7):1233-1238.
31. Koopmans G.T., Lamers L.M. Gender and health care utilization: the role of mental distress and help-seeking propensity. Social Science & Medicine 2007, 64(6):1216-1230.
32. Lagergren M., Fratiglioni L., Hallberg I.R., et al. A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC). Aging Clinical and Experimental Research 2004, 16(2):158-168.
33. Linjakumpu T., Hartikainen S., Klaukka T., Veijola J., Kivela S.L., Isoaho R. Use of medications and polypharmacy are increasing among the elderly. Journal of Clinical Epidemiology 2002, 55(8):809-817.
34. Linjakumpu T., Hartikainen S., Klaukka T., Koponen H., Kivela S.L., Isoaho R. Psychotropics among the home-dwelling elderly-increasing trends. International Journal of Geriatric Psychiatry 2002, 17(9):874-883.
35. Mazer-Amirshahi M., Mullins P.M., Rasooly I., van den Anker J., Pines J.M. Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010. Academic Emergency Medicine 2014, 21(3):236-243.
36. Medical Products Agency Prevention of atherosclerotic cardiovascular disease with drugs-treatment recommendation. Att förebygga aterosklerotisk hjärt-kärlsjukdom med läkemedel-behandlingsrekommendation. Läkemedelsverket 2014, 25(5):20-33.
37. Nobili A., Franchi C., Pasina L., et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiology and Drug Safety 2011, 20(5):488-496.
38. OECD Health at a glance 2013: OECD indicators 2013, OECD, Paris.
39. Olsen Y., Daumit G.L., Ford D.E. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. Journal of Pain 2006, 7(4):225-235.
40. Parsons C., Johnston S., Mathie E., et al. Potentially inappropriate prescribing in older people with dementia in care homes: a retrospective analysis. Drugs & Aging 2012, 29(2):143-155.
41. Qato D.M., Alexander G.C., Conti R.M., Johnson M., Schumm P., Lindau S.T. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008, 300(24):2867-2878.
42. Shi S., Morike K., Klotz U. The clinical implications of ageing for rational drug therapy. European Journal of Clinical Pharmacology 2008, 64(2):183-199.
43. Tinetti M.E., Bogardus S.T., Agostini J.V. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. New England Journal of Medicine 2004, 351(27):2870-2874.
44. von Strauss E., Aguero-Torres H., Kareholt I., Winblad B., Fratiglioni L. Women are more disabled in basic activities of daily living than men only in very advanced ages: a study on disability, morbidity, and mortality from the Kungsholmen Project. Journal of Clinical Epidemiology 2003, 56(7):669-677.
45. Van Spall H.G., Toren A., Kiss A., Fowler R.A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 21 2007, 297(11):1233-1240.
46. Verhaak P.F., Dekker J.H., de Waal M.W., van Marwijk H.W., Comijs H.C. Depression, disability and somatic diseases among elderly. Journal of Affective Disorders 2014, 167:187-191.
47. WHO. Collaboration Centre for Drug Statistics Methodology. ATC/DDD Index 2014. (2013). Accessed 02.04.14.
48. Wimmer B.C., Dent E., Bell J.S., et al. Medication regimen complexity and unplanned hospital readmissions in older people. The Annals of Pharmacotherapy 2014, 48(9):1120-1128.
49. Wimmer B.C., Dent E., Visvanathan R., et al. Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: a prospective cohort study. Drugs & Aging 2014, 31(8):623-630.